Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Campus
Campus

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
LDL-C The Only Causal Risk Factor for ASCVD

LDL-C The Only Causal Risk Factor for ASCVD

Learn more
Benefit of Prophylaxis for High-Risk Surgical Patients

Benefit of Prophylaxis for High-Risk Surgical Patients

Learn more
Pompe

Pompe

Learn more
About Type 2 Inflammation – Nasal Polyps

About Type 2 Inflammation – Nasal Polyps

Learn more
Slowing of brain atrophy with Teriflunomide

Slowing of brain atrophy with Teriflunomide

Learn more
Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Learn more
Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Learn more
Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Learn more
Trends in Pulmonary Embolism-related mortality in Europe

Trends in Pulmonary Embolism-related mortality in Europe

An analysis of vital registration data from the WHO Mortality Database (2000-2015).

Learn more
2019 ESC Guidelines for Acute Pulmonary Embolism

2019 ESC Guidelines for Acute Pulmonary Embolism

The guidelines provide an update on the 2014 guidelines.

Learn more
CV Risk management in T1DM using guidelines

CV Risk management in T1DM using guidelines

Learn more
Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.

Learn more